Pop­u­lar biotech boost­ers get­ting mul­ti­mil­lion-dol­lar pay­outs on Wall Street as top an­a­lysts are wooed with big of­fers — WSJ

If you’re one of those Wall Street an­a­lysts who en­joys noth­ing quite as much as build­ing a fire of an­tic­i­pa­tion un­der a biotech stock, your day has ar­rived.

The Wall Street Jour­nal to­day man­aged to track some of the big pay­days await­ing the biotech an­a­lysts who have been jump­ing ship from one bank group to an­oth­er. And there are three in­vest­ment banks that are mak­ing some of­fers that are all but im­pos­si­ble to refuse: Leerink Part­ners, Can­tor Fitzger­ald and Jef­feries Group.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER